We are live on ! Find out more
BOCH

Blue Owl Capital Holdings Portfolio holdings

AUM $372M
1-Year Est. Return 78.25%
This Fund
S&P 500
This Quarter Est. Return
+27.71%
1 Year Est. Return
+78.25%
3 Year Est. Return
+112.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$322M
AUM Growth
+$12.3M
Cap. Flow
-$21.1M
Cap. Flow %
-6.55%
Top 10 Hldgs %
61.66%
Holding
80
New
8
Increased
8
Reduced
12
Closed
8

Top Buys

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$12.2M
2
RARE icon
Ultragenyx Pharmaceutical
RARE
+$5.01M
3
DELL icon
Dell
DELL
+$4.09M
4
LRMR icon
Larimar Therapeutics
LRMR
+$3.47M
5
IMRX icon
Immuneering
IMRX
+$2.85M

Top Sells

Rank Stock Value
1
TRML
Tourmaline Bio
TRML
+$15.9M
2
NCDL icon
Nuveen Churchill Direct Lending
NCDL
+$15.2M
3
TEM
Tempus AI
TEM
+$5.09M
4
MLYS icon
Mineralys Therapeutics
MLYS
+$5.08M
5
TNGX icon
Tango Therapeutics
TNGX
+$4.7M

Sector Composition

Rank Sector Weight
1 Healthcare 56.77%
2 Financials 22.9%
3 Technology 12.32%
4 Consumer Discretionary 7.01%
5 Energy 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAICW
51
CID HoldCo Inc Warrants
DAICW
$78.4K
$45.8K 0.01%
300,000
– –
AEON icon
52
AEON Biopharma
AEON
$13.7M
$34.2K 0.01%
42,353
– –
DAVEW icon
53
Dave Inc Warrants
DAVEW
$13.7M
$31.2K 0.01%
28,750
– –
LVWR.WS icon
54
LiveWire Group Warrants
LVWR.WS
$6.51M
$29K 0.01%
400,000
– –
ENGNW icon
55
enGene Therapeutics Warrants
ENGNW
$5M
$25.6K 0.01%
36,100
– –
BNAIW
56
Brand Engagement Network Warrant
BNAIW
$2.16M
$25.5K 0.01%
1,666,808
– –
PGYWW
57
Pagaya Technologies Ltd Warrants
PGYWW
$1.34M
$24.3K 0.01%
48,661
– –
RDZNW icon
58
Roadzen Inc Warrants
RDZNW
$7.92M
$15.8K ﹤0.01%
225,000
– –
NVNIW
59
Nvni Group Limited Warrants
NVNIW
$836K
$14.4K ﹤0.01%
200,000
– –
ZEOWW
60
Zeo Energy Corp Warrants
ZEOWW
$13.8K ﹤0.01%
250,000
– –
BTMWW
61
DELISTED
Bitcoin Depot Inc Warrant
BTMWW
$12.4K ﹤0.01%
50,000
– –
TVGNW icon
62
Tevogen Inc. Warrant
TVGNW
$821K
$11.1K ﹤0.01%
200,000
– –
LIMNW
63
Liminatus Pharma Warrants
LIMNW
$7.39K ﹤0.01%
50,000
– –
BDMDW
64
Baird Medical Investment Holdings Warrant
BDMDW
$6.7K ﹤0.01%
100,000
– –
BSLKW
65
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$6.67K ﹤0.01%
166,666
– –
CEROW
66
DELISTED
CERo Therapeutics Warrants
CEROW
$2.99K ﹤0.01%
224,930
– –
KPLTW
67
DELISTED
Katapult Holdings Warrant
KPLTW
$2.72K ﹤0.01%
400,000
– –
ASBPW
68
Aspire Biopharma Warrant
ASBPW
$1.5K ﹤0.01%
50,000
– –
WALDW icon
69
Waldencast PLC Warrant
WALDW
$3.8M
$1.23K ﹤0.01%
33,333
– –
XBPEW
70
XBP Europe Holdings Warrant
XBPEW
$994 ﹤0.01%
24,778
– –
SDSTW
71
Stardust Power Inc Warrant
SDSTW
$447 ﹤0.01%
16,666
– –
VRNA
72
DELISTED
Verona Pharma
VRNA
$98 ﹤0.01%
18,347
– –
APGE icon
73
Apogee Therapeutics
APGE
$10.2B
– –
-35,000
Closed -$1.52M
BMEA icon
74
Biomea Fusion
BMEA
$90.6M
– –
-1,300,000
Closed -$2.34M
CABA icon
75
Cabaletta Bio
CABA
$448M
– –
-1,125,000
Closed -$1.71M
1 2
3
4

Similar funds

PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
GIP
Gavilan Investment Partners Burlingame, California $372M AUM 6.04% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return
JC
Joho Capital New York $373M AUM 18.89% 1-Year Est. Return

Blue Owl Capital Holdings's Q3 2025 Portfolio in Review

As of Q3 2025, Blue Owl Capital Holdings held 80 positions worth $322M, up 4% from $310M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Blue Owl Capital Holdings withdrew a net $21.1M in Q3 2025, closing 8 positions and reducing 12 holdings. Its most notable exit was Tourmaline Bio, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 51% a quarter earlier, followed by Financials and Technology.

Against the trend, Blue Owl Capital Holdings opened a new position in Roivant Sciences worth $15M.

  • Blue Owl Capital Holdings's largest Q3 2025 buy was Roivant Sciences: 988,249 shares worth $15M.
  • Blue Owl Capital Holdings added most to Ultragenyx Pharmaceutical in Q3 2025, an estimated $5.01M increase.
  • Blue Owl Capital Holdings's biggest Q3 2025 reduction was Nuveen Churchill Direct Lending, cutting an estimated $15.2M.
  • Blue Owl Capital Holdings fully exited Tourmaline Bio in Q3 2025, selling an estimated $15.9M.
  • Blue Owl Capital Holdings's ten largest holdings make up 62% of its $322M portfolio in Q3 2025.
  • Blue Owl Capital Holdings opened 8 new positions and closed 8 in Q3 2025.
  • Blue Owl Capital Holdings's portfolio value rose 4% quarter-over-quarter to $322M.

Based on Blue Owl Capital Holdings's 13F filing for Q3 2025, filed 12 Nov 2025.